Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 10.92 is 24% below its 5-year average of 14.39, near the low end of its 5-year range (4.91–28.63).
As of the fiscal period ended Tuesday, June 30, 2026. 18.91% below its 12-month average of 13.46.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 10.92.
QUICK RATIO (ACID-TEST)
10.92
QUICK RATIO (ACID-TEST) AVG TTM
13.46
QUICK RATIO (ACID-TEST) AVG 3Y
15.87
QUICK RATIO (ACID-TEST) AVG 5Y
14.39
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-18.91%
CURRENT VS 3Y AVG
-31.20%
CURRENT VS 5Y AVG
-24.15%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
+225.38%
vs the sector median at left
Vera Therapeutics, Inc.
Market Cap
$2.11B
Quick Ratio (Acid-Test)
10.92
TTM Avg
13.46
3Y Avg
15.87
5Y Avg
14.39
Market Cap
$2.11B
Quick Ratio (Acid-Test)
1.69
TTM Avg
1.73
3Y Avg
1.64
5Y Avg
1.89
Market Cap
$2.11B
Quick Ratio (Acid-Test)
18.83
TTM Avg
6.22
3Y Avg
3.45
5Y Avg
3.57
Market Cap
$2.13B
Quick Ratio (Acid-Test)
3.06
TTM Avg
2.88
3Y Avg
2.52
5Y Avg
2.76
Market Cap
$2.06B
Quick Ratio (Acid-Test)
16.95
TTM Avg
14.04
3Y Avg
14.82
5Y Avg
14.35
Market Cap
$2.06B
Quick Ratio (Acid-Test)
11.82
TTM Avg
14.70
3Y Avg
15.08
5Y Avg
16.52
Market Cap
$2.17B
Quick Ratio (Acid-Test)
2.98
TTM Avg
6.17
3Y Avg
6.76
5Y Avg
6.11
Market Cap
$2.05B
Quick Ratio (Acid-Test)
4.69
TTM Avg
4.29
3Y Avg
4.33
5Y Avg
4.67
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vera Therapeutics, Inc. (VERA) | $2.11B | 10.92 | 13.46 | 15.87 | 14.39 |
| Addus HomeCare Corporation (ADUS)vs › | $2.11B | 1.69 | 1.73 | 1.64 | 1.89 |
| SELLAS Life Sciences Group, Inc. (SLS)vs › | $2.11B | 18.83 | 6.22 | 3.45 | 3.57 |
| GeneDx Holdings Corp. (WGS)vs › | $2.13B | 3.06 | 2.88 | 2.52 | 2.76 |
| Alvotech (ALVO)vs › | $2.08B | 0.96 | 1.42 | 1.06 | 1.08 |
| Viridian Therapeutics, Inc. (VRDN)vs › | $2.06B | 16.95 | 14.04 | 14.82 | 14.35 |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.06B | 11.82 | 14.70 | 15.08 | 16.52 |
| Maravai LifeSciences Holdings, Inc. (MRVI)vs › | $2.17B | 2.98 | 6.17 | 6.76 | 6.11 |
| Vericel Corporation (VCEL)vs › | $2.05B | 4.69 | 4.29 | 4.33 | 4.67 |
| Pharvaris N.V. (PHVS)vs › | $2.17B | 11.94 | 11.36 | 14.72 | 18.03 |
Quick Ratio
10.92
Excludes inventory
Current Ratio
10.92
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 10.92 |
| 2026-03-31 | 13.64 |
| 2025-12-31 | 13.64 |
| 2025-09-30 | 12.09 |
| 2025-06-30 | 17.03 |
| 2025-03-31 | 27.68 |
| 2024-12-31 | 25.67 |
| 2024-09-30 | 13.76 |
| 2024-06-30 | 21.43 |
| 2024-03-31 | 28.63 |
| 2023-12-31 | 7.71 |
| 2023-09-30 | 6.97 |
| 2023-06-30 | 7.10 |
| 2023-03-31 | 8.69 |
| 2022-12-31 | 4.91 |
| 2022-09-30 | 7.85 |
| 2022-06-30 | 8.24 |
| 2022-03-31 | 7.90 |
| 2021-12-31 | 10.73 |
| 2021-09-30 | 22.21 |
| 2021-06-30 | 25.42 |
| 2021-03-31 | 13.73 |
| 2020-12-31 | 22.55 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
